If Apple wants to add new medical device-like health monitoring features to its Apple Watch, will the company need to go to the Food and Drug Administration (FDA) for review?
The question gained momentum recently with rumors that Apple is trying to develop a device which would let patients check blood sugar by touching their skin rather than using a painful pin prick, according to news reports.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
